메뉴 건너뛰기




Volumn 40, Issue 5, 2014, Pages 1047-1052

The reliability and validity of the MATRICS functional assessment battery

Author keywords

Co primary measures; Cognitive impairments; Functional capacity measures; Intermediate measures; International clinical trials; Schizophrenia

Indexed keywords

AMPHETAMINE; CLOZAPINE; MONOAMINE OXIDASE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

EID: 84907354903     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt148     Document Type: Article
Times cited : (20)

References (25)
  • 1
    • 4444220908 scopus 로고    scopus 로고
    • Approaching a consensus cognitive battery for clinical trials in schizophrenia: The nimh-matrics conference to select cognitive domains and test criteria
    • Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004;56: 301-307.
    • (2004) Biol Psychiatry. , vol.56 , pp. 301-307
    • Green, M.F.1    Nuechterlein, K.H.2    Gold, J.M.3
  • 2
    • 26444587625 scopus 로고    scopus 로고
    • Distinguishing separable domains of cognition in human and animal studies: What separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference
    • Nuechterlein KH, Robbins TW, Einat H. Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull. 2005;31: 870-874.
    • (2005) Schizophr Bull. , vol.31 , pp. 870-874
    • Nuechterlein, K.H.1    Robbins, T.W.2    Einat, H.3
  • 3
    • 20844439028 scopus 로고    scopus 로고
    • A summary of the fda-nimh-matrics workshop on clinical trial design for neurocognitive drugs for schizophrenia
    • Buchanan RW, Davis M, Goff D, et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull. 2005;31: 5-19.
    • (2005) Schizophr Bull. , vol.31 , pp. 5-19
    • Buchanan, R.W.1    Davis, M.2    Goff, D.3
  • 4
    • 40949097635 scopus 로고    scopus 로고
    • The matrics consensus cognitive battery, part 1: Test selection, reliability, and validity
    • Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165: 203-213.
    • (2008) Am J Psychiatry. , vol.165 , pp. 203-213
    • Nuechterlein, K.H.1    Green, M.F.2    Kern, R.S.3
  • 5
    • 40949109613 scopus 로고    scopus 로고
    • The matrics consensus cognitive battery, part 2: Co-norming and standardization
    • Kern RS, Nuechterlein KH, Green MF, et al. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry. 2008;165: 214-220.
    • (2008) Am J Psychiatry. , vol.165 , pp. 214-220
    • Kern, R.S.1    Nuechterlein, K.H.2    Green, M.F.3
  • 6
    • 40949145164 scopus 로고    scopus 로고
    • Functional coprimary measures for clinical trials in schizophrenia: Results from the matrics psychometric and standardization study
    • Green MF, Nuechterlein KH, Kern RS, et al. Functional coprimary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry. 2008;165: 221-228.
    • (2008) Am J Psychiatry. , vol.165 , pp. 221-228
    • Green, M.F.1    Nuechterlein, K.H.2    Kern, R.S.3
  • 7
    • 79955137651 scopus 로고    scopus 로고
    • Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia
    • Green MF, Schooler NR, Kern RS, et al. Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry. 2011;168: 400-407.
    • (2011) Am J Psychiatry. , vol.168 , pp. 400-407
    • Green, M.F.1    Schooler, N.R.2    Kern, R.S.3
  • 8
    • 0035222398 scopus 로고    scopus 로고
    • Ucsd performance-based skills assessment: Development of a new measure of everyday functioning for severely mentally ill adults
    • Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27: 235-245.
    • (2001) Schizophr Bull. , vol.27 , pp. 235-245
    • Patterson, T.L.1    Goldman, S.2    McKibbin, C.L.3    Hughs, T.4    Jeste, D.V.5
  • 9
    • 34247362923 scopus 로고    scopus 로고
    • The reliability and validity of the test of adaptive behavior in schizophrenia (tabs)
    • Velligan DI, Diamond P, Glahn DC, et al. The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS). Psychiatry Res. 2007;151: 55-66.
    • (2007) Psychiatry Res. , vol.151 , pp. 55-66
    • Velligan, D.I.1    Diamond, P.2    Glahn, D.C.3
  • 10
    • 84860166018 scopus 로고    scopus 로고
    • The cultural adaptability of intermediate measures of functional outcome in schizophrenia
    • Velligan DI, Rubin M, Fredrick MM, et al. The cultural adaptability of intermediate measures of functional outcome in schizophrenia. Schizophr Bull. 2012;38: 630-641.
    • (2012) Schizophr Bull. , vol.38 , pp. 630-641
    • Velligan, D.I.1    Rubin, M.2    Fredrick, M.M.3
  • 13
    • 0020819764 scopus 로고
    • Slof: A behavioral rating scale for assessing the mentally ill
    • Schneider LC, Struening EL. SLOF: a behavioral rating scale for assessing the mentally ill. Soc Work Res Abstr. 1983;19: 9-21.
    • (1983) Soc Work Res Abstr. , vol.19 , pp. 9-21
    • Schneider, L.C.1    Struening, E.L.2
  • 14
    • 0023606101 scopus 로고
    • The positive and negative syndrome scale (panss) for schizophrenia
    • Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13: 261-276.
    • (1987) Schizophr Bull. , vol.13 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 15
    • 0031431410 scopus 로고    scopus 로고
    • The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the north american trials
    • Marder SR, Davis JM, Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry. 1997;58: 538-546.
    • (1997) J Clin Psychiatry. , vol.58 , pp. 538-546
    • Marder, S.R.1    Davis, J.M.2    Chouinard, G.3
  • 16
    • 0004990351 scopus 로고
    • A test of the hypothesis that cronbach's alpha reliability coefficient is the same for two tests administered to the same sample
    • Feldt LS. A test of the hypothesis that Cronbach's alpha reliability coefficient is the same for two tests administered to the same sample. Psychometrika. 1980;45: 99-105.
    • (1980) Psychometrika. , vol.45 , pp. 99-105
    • Feldt, L.S.1
  • 19
    • 0040669456 scopus 로고    scopus 로고
    • Testing the equality of dependent intraclass correlation coefficients
    • Donner A, Zou G. Testing the equality of dependent intraclass correlation coefficients. J R Stat Soc Series D (The Statistician). 2002;51: 367-379.
    • (2002) J R Stat Soc Series D (The Statistician). , vol.51 , pp. 367-379
    • Donner, A.1    Zou, G.2
  • 21
    • 48249153186 scopus 로고
    • Intraclass correlations: Uses in assessing rater reliability
    • Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86: 420-428.
    • (1979) Psychol Bull. , vol.86 , pp. 420-428
    • Shrout, P.E.1    Fleiss, J.L.2
  • 22
    • 0036235184 scopus 로고    scopus 로고
    • Test-retest stability of the repeatable battery for the assessment of neuropsychological status in schizophrenia
    • Wilk CM, Gold JM, Bartko JJ, et al. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. Am J Psychiatry. 2002;159: 838-844.
    • (2002) Am J Psychiatry. , vol.159 , pp. 838-844
    • Wilk, C.M.1    Gold, J.M.2    Bartko, J.J.3
  • 23
    • 0029918481 scopus 로고    scopus 로고
    • What are the functional consequences of neurocognitive deficits in schizophrenia?
    • Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153: 321-330.
    • (1996) Am J Psychiatry. , vol.153 , pp. 321-330
    • Green, M.F.1
  • 24
    • 84874343719 scopus 로고    scopus 로고
    • Technology, society, and mental illness: Challenges and opportunities for assessment and treatment
    • Harvey PD, Se Keefe R. Technology, society, and mental illness: challenges and opportunities for assessment and treatment. Innov Clin Neurosci. 2012;9: 47-50.
    • (2012) Innov Clin Neurosci. , vol.9 , pp. 47-50
    • Harvey, P.D.1    Se Keefe, R.2
  • 25
    • 49049107813 scopus 로고    scopus 로고
    • Feasibility and validity of computerized ecological momentary assessment in schizophrenia
    • Granholm E, Loh C, Swendsen J. Feasibility and validity of computerized ecological momentary assessment in schizophrenia. Schizophr Bull. 2008;34: 507-514.
    • (2008) Schizophr Bull. , vol.34 , pp. 507-514
    • Granholm, E.1    Loh, C.2    Swendsen, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.